| 1 |
35443722 | Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis. | 2022 Apr 20 |
5 |
| 2 |
34707185 | CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1. | 2021 Oct 27 |
2 |
| 3 |
34718324 | A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia. | 2021 Oct 30 |
1 |
| 4 |
29872325 | miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells. | 2018 |
1 |
| 5 |
30361682 | Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML. | 2018 Oct 25 |
1 |
| 6 |
27103402 | Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells. | 2016 Sep 1 |
3 |
| 7 |
27462781 | Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells. | 2016 Aug 30 |
1 |
| 8 |
23441221 | Chemoresistance of human monocyte-derived dendritic cells is regulated by IL-17A. | 2013 |
1 |
| 9 |
22829255 | Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies. | 2012 Mar |
1 |
| 10 |
21212792 | The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine. | 2011 Mar |
2 |
| 11 |
16818278 | The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells. | 2006 Jul |
1 |
| 12 |
11830549 | An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine. | 2002 Feb 1 |
1 |